Franklin Strategic Biotechnology Discovery Fund Class A
Franklin Strategic Biotechnology Discovery Fund Class A (FBDIX)
The Franklin Strategic Biotechnology Discovery Fund Class A (FBDIX) is a mutual fund that focuses on investing in companies within the biotechnology industry. This fund aims to discover and capitalize on emerging trends and breakthroughs in the biotech sector, providing potential for long-term growth and capital appreciation. With a strategic approach to investing, FBDIX seeks to provide investors with exposure to a diverse range of biotech companies, including both established players and up-and-coming innovators. As a Class A fund, FBDIX may have lower fees and expenses compared to other share classes, making it an attractive option for investors looking to enter the biotech market.
FBDIX Mutual Fund Chart & Stats
- Previous Close
- $187.28
- Sub-Category
- Sector-Specific
- Total Liabilities
- $37.83M
- Expense Ratio
- 1.01%
- Holding Count
- 108
- Brand
- Franklin Strategic Series
- Category
- Equity
- Total Assets
- 1.19B
- Shares Outstanding
- N/A
- 52-Week Range
- $160.28 - $226.20
FBDIX Mutual Fund News
FBDIX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| JAZZJazz Pharmaceuticals | 5.66% |
| AMGNAmgen Inc | 4.39% |
| GILDGilead Sciences | 3.86% |
| REGNRegeneron Pharmaceuticals | 3.77% |
| ARGXArgenx | 3.62% |
| VRTXVertex Pharmaceuticals Inc. | 3.54% |
| USD_CASHFranklin Institutional U.S. Government Money Market Fund | 3.18% |
| RVMDRevolution Medicines, Inc. | 3.01% |
| GHGuardant Health | 2.76% |
| ASNDAscendis Pharma A/S | 2.56% |
| Total | 36.34% |
Recently Viewed
No data currently available






